国产精品99一区二区三_免费中文日韩_国产在线精品一区二区_日本成人手机在线

Source of damaging inflammation after heart attack identified: study

Source: Xinhua| 2018-06-08 06:23:42|Editor: yan
Video PlayerClose

CHICAGO, June 7 (Xinhua) -- Researchers at Washington University School of Medicine in St. Louis have zeroed in on B cells that try to heal the injured heart following a heart attack but instead trigger inflammation that leads to even more damage.

The study is published June 7 in JCI Insight.

And they also found that an already approved drug, Pirfenidone, effectively tamps down such inflammation in mice, protecting the heart from the progressive damage that often occurs after a heart attack.

The researchers' immune studies of the heart still focus on other types of immune cells, including macrophages, T cell lymphocytes, neutrophils and monocytes. They first did not find any differences in the numbers of such immune cells in the injured hearts of mice that received pirfenidone versus those that didn't. But when they serendipitously measured B cells, they saw a huge difference.

"Our results showing B cells driving heart inflammation was quite unexpected," said first author Luigi Adamo, a clinical fellow in cardiology. "We didn' t know that B cells have a role in the type of heart damage we were studying until our data pushed us in that direction. We also found that there isn't just one type of B cell in the heart, but a whole family of different types that are closely related. And pirfenidone modulates these cells to have a protective effect on heart muscle after a heart attack."

When these cells were removed completely, not only was the heart not protected, the beneficial effect of the drug went away. So the B cells are not exclusively bad, the researchers said.

"The protective effects of pirfenidone hinge on the presence of B cells," Adamo said. "The drug may be working on other cells as well, perhaps directly or perhaps through the B cells. We're continuing to investigate the details."

Pirfenidone, a drug approved by the Food and Drug Administration to treat a lung condition called idiopathic pulmonary fibrosis, has long been considered safe. But it can have such side effects as nausea and vomiting.

Now that the researchers have identified B cell lymphocytes as the drug's target, they can begin investigating ways to make it better.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011105521372383231
主站蜘蛛池模板: 扶沟县| 庄河市| 青州市| 湘潭县| 海晏县| 泉州市| 天柱县| 博罗县| 鹤岗市| 墨竹工卡县| 昌黎县| 永登县| 清流县| 常宁市| 红安县| 瑞丽市| 包头市| 新沂市| 天柱县| 乌恰县| 和平区| 溧水县| 盖州市| 龙川县| 乐安县| 漯河市| 桐柏县| 房山区| 德保县| 密云县| 唐河县| 迁西县| 甘孜县| 岱山县| 清苑县| 高唐县| 山西省| 平潭县| 高清| 永城市| 沾益县|